RG
BCRX icon

Redmile Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Redmile Group’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-75,000
Closed -$215K – 66
2019
Q3 		$215K Buy
+75,000
New +$215K 0.01% 70